Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 ...

As a leading international institution ranked among the top universities globally, HKUST is extending this opportunity to ensure talented students can pursue their educational goals without disruption ...

Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

Indian markets opened higher, driven by ITC and IT stocks, but concerns over foreign fund outflows and the U.S. fiscal ...

The NYSE debut is the first major IPO for a venture-backed digital-health company since the pandemic-era boom. The top lender, advised by law firm Paul Weiss, is in discussions to take over the ...

The Chinese drugmaker raised HK$9.74 billion, equivalent to US$1.25 billion, in net proceeds, making it one of Hong Kong's largest IPOs so far this year. The stock was priced at HK$44.05 per share, ...

Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

On the global front, Asian markets traded mostly higher today as investors assess a slew of economic data from the region.

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, began trading on the Hong Kong stock exchange on Friday, ...

Robin Zeng’s high-stakes bets—from quitting his first job to founding CATL—have reshaped the global EV battery market.

For years, Dominari Holdings’ shifting priorities and tribulations remained largely out of the spotlight. That changed when ...

ONE of the assumed pressure points in the ongoing nonviolent dispute between the United States and China is the latter's ...